ARCHIVES

NCI Halts Routine P01 Site Visits Due to Travel Cut

This article is from The Cancer Letter archive.

Vol. 18 No. 06 | February 7, 1992

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

HCFA Chief Says Facts Will Not Matter, She Won’t Loosen DRGs For Clinical Trials Unless Congress Orders It

May 4, 1984

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014